IMAX/$IMAX
1D1W1MYTD1Y5YMAX
Capital at risk
About IMAX
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
- Ticker
- $IMAX
- Sector
- Consumer Discretionary
- Primary listing
- NYSE
- Employees
- 679
- Headquarters
- Mississauga, Canada
- Website
- www.imax.com
IMAX Metrics
BasicAdvanced
$2.9B
72.41
$0.73
0.37
-
Price and volume
Market cap
$2.9B
Beta
0.37
52-week high
$55.57
52-week low
$30.74
Average daily volume
1M
Financial strength
Current ratio
4.264
Quick ratio
3.796
Long term debt to equity
0.627
Total debt to equity
0.627
Interest coverage (TTM)
12.69%
Profitability
EBITDA (TTM)
138.217
Gross margin (TTM)
59.73%
Net profit margin (TTM)
9.84%
Operating margin (TTM)
22.84%
Effective tax rate (TTM)
24.40%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
6.65%
Return on equity (TTM)
11.02%
Valuation
Price to earnings (TTM)
72.41
Price to revenue (TTM)
6.871
Price to book
8.13
Price to tangible book (TTM)
10.32
Price to free cash flow (TTM)
28.59
Free cash flow yield (TTM)
3.50%
Free cash flow per share (TTM)
1.846
Growth
Revenue change (TTM)
14.79%
Earnings per share change (TTM)
21.99%
3-year revenue growth (CAGR)
5.76%
10-year revenue growth (CAGR)
0.71%
3-year earnings per share growth (CAGR)
107.66%
10-year earnings per share growth (CAGR)
0.51%
What the Analysts think about IMAX
Analyst ratings (Buy, Hold, Sell) for IMAX stock.
Analyst projections of the future price of IMAX stock.
Bulls say / Bears say
IMAX reported Q2 2026 revenue of $103 million, up 12% year-over-year, with record Q2 adjusted EPS of $0.43 (+65%), net income margin of 15.5%, and adjusted EBITDA margin of 46.6%, reflecting strong operational leverage. (Yahoo Finance)
Christopher Nolan’s The Odyssey delivered a record-breaking $52 million opening weekend in IMAX theaters, capturing 20% of the film’s global box office debut and generating approximately $60 million in presales, demonstrating the company's pricing power and brand appeal. (Street Insider)
IMAX installed 38 new systems in Q2 2026—the highest quarterly installations in a decade—and expanded its global footprint by 9% year-over-year to 1,809 systems, maintaining a robust backlog of 421 systems, underscoring strong demand for its premium theater technology. (SEC)
Total debt excluding deferred financing costs remained elevated at approximately $282.6 million as of June 30, 2026, versus cash and cash equivalents of $159.9 million, leaving IMAX with a net leverage position that could constrain financial flexibility amid rising interest rates. (SEC)
Content Solutions segment gross margin declined 2% year-over-year to $22 million in Q2 2026, suggesting margin pressure from higher remastering costs or competitive pricing in film services. (SEC)
Global box office revenues grew only 1% year-over-year to $285 million in Q2 2026—the smallest quarterly increase since 2019—indicating a potential plateau in theatrical recovery and vulnerability to streaming alternatives. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2026.
IMAX Financial Performance
Revenues and expenses
IMAX Earnings Performance
Company profitability
Upcoming events
No upcoming events
IMAX News
AllArticlesVideos
Funds containing IMAX
AllEURGBPUSD
Fund name | Fund size | $IMAX weighting |
|---|---|---|
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.09% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.09% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.08% |
iShares MSCI World Small Cap$WSML | $9B | 0.03% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.03% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.